154 related articles for article (PubMed ID: 10697113)
1. Deletion of the adenoviral E1b-19kD gene enhances tumor cell killing of a replicating adenoviral vector.
Sauthoff H; Heitner S; Rom WN; Hay JG
Hum Gene Ther; 2000 Feb; 11(3):379-88. PubMed ID: 10697113
[TBL] [Abstract][Full Text] [Related]
2. Wild-type adenovirus decreases tumor xenograft growth, but despite viral persistence complete tumor responses are rarely achieved--deletion of the viral E1b-19-kD gene increases the viral oncolytic effect.
Harrison D; Sauthoff H; Heitner S; Jagirdar J; Rom WN; Hay JG
Hum Gene Ther; 2001 Jul; 12(10):1323-32. PubMed ID: 11440625
[TBL] [Abstract][Full Text] [Related]
3. Functional interactions of antiapoptotic proteins and tumor necrosis factor in the context of a replication-competent adenovirus.
Liu TC; Wang Y; Hallden G; Brooks G; Francis J; Lemoine NR; Kirn D
Gene Ther; 2005 Sep; 12(17):1333-46. PubMed ID: 15920462
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of E1B gene-attenuated replicating adenoviruses for cancer gene therapy.
Kim J; Cho JY; Kim JH; Jung KC; Yun CO
Cancer Gene Ther; 2002 Sep; 9(9):725-36. PubMed ID: 12189522
[TBL] [Abstract][Full Text] [Related]
5. Markedly enhanced cytolysis by E1B-19kD-deleted oncolytic adenovirus in combination with cisplatin.
Yoon AR; Kim JH; Lee YS; Kim H; Yoo JY; Sohn JH; Park BW; Yun CO
Hum Gene Ther; 2006 Apr; 17(4):379-90. PubMed ID: 16610926
[TBL] [Abstract][Full Text] [Related]
6. Targeting the replication of adenoviral gene therapy vectors to lung cancer cells: the importance of the adenoviral E1b-55kD gene.
Hay JG; Shapiro N; Sauthoff H; Heitner S; Phupakdi W; Rom WN
Hum Gene Ther; 1999 Mar; 10(4):579-90. PubMed ID: 10094201
[TBL] [Abstract][Full Text] [Related]
7. Adenovirus E1B 19-kilodalton protein modulates innate immunity through apoptotic mimicry.
Radke JR; Grigera F; Ucker DS; Cook JL
J Virol; 2014 Mar; 88(5):2658-69. PubMed ID: 24352454
[TBL] [Abstract][Full Text] [Related]
8. Late expression of p53 from a replicating adenovirus improves tumor cell killing and is more tumor cell specific than expression of the adenoviral death protein.
Sauthoff H; Pipiya T; Heitner S; Chen S; Norman RG; Rom WN; Hay JG
Hum Gene Ther; 2002 Oct; 13(15):1859-71. PubMed ID: 12396618
[TBL] [Abstract][Full Text] [Related]
9. The role of the E1B 55 kDa gene product in oncolytic adenoviral vectors expressing herpes simplex virus-tk: assessment of antitumor efficacy and toxicity.
Wildner O; Morris JC
Cancer Res; 2000 Aug; 60(15):4167-74. PubMed ID: 10945625
[TBL] [Abstract][Full Text] [Related]
10. Modification of the p53 transgene of a replication-competent adenovirus prevents mdm2- and E1b-55kD-mediated degradation of p53.
Sauthoff H; Pipiya T; Chen S; Heitner S; Cheng J; Huang YQ; Rom WN; Hay JG
Cancer Gene Ther; 2006 Jul; 13(7):686-95. PubMed ID: 16470212
[TBL] [Abstract][Full Text] [Related]
11. E1A-induced apoptosis does not prevent replication of adenoviruses with deletion of E1b in majority of infected cancer cells.
Rao XM; Tseng MT; Zheng X; Dong Y; Jamshidi-Parsian A; Thompson TC; Brenner MK; McMasters KM; Zhou HS
Cancer Gene Ther; 2004 Sep; 11(9):585-93. PubMed ID: 15338010
[TBL] [Abstract][Full Text] [Related]
12. E1A- and E1B-Double mutant replicating adenovirus elicits enhanced oncolytic and antitumor effects.
Kim J; Kim JH; Choi KJ; Kim PH; Yun CO
Hum Gene Ther; 2007 Sep; 18(9):773-86. PubMed ID: 17725410
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the recombinant adenovirus vector AdYB-1: implications for oncolytic vector development.
Glockzin G; Mantwill K; Jurchott K; Bernshausen A; Ladhoff A; Royer HD; Gansbacher B; Holm PS
J Virol; 2006 Apr; 80(8):3904-11. PubMed ID: 16571807
[TBL] [Abstract][Full Text] [Related]
14. Treatment of malignant gliomas with a replicating adenoviral vector expressing herpes simplex virus-thymidine kinase.
Nanda D; Vogels R; Havenga M; Avezaat CJ; Bout A; Smitt PS
Cancer Res; 2001 Dec; 61(24):8743-50. PubMed ID: 11751394
[TBL] [Abstract][Full Text] [Related]
15. Gene therapy for bladder cancer using E1B-55 kD-deleted adenovirus in combination with adenoviral vector encoding plasminogen kringles 1-5.
Hsieh JL; Wu CL; Lai MD; Lee CH; Tsai CS; Shiau AL
Br J Cancer; 2003 May; 88(9):1492-9. PubMed ID: 12778082
[TBL] [Abstract][Full Text] [Related]
16. DNA replication of first-generation adenovirus vectors in tumor cells.
Steinwaerder DS; Carlson CA; Lieber A
Hum Gene Ther; 2000 Sep; 11(13):1933-48. PubMed ID: 10986565
[TBL] [Abstract][Full Text] [Related]
17. Replication and cytolysis of an E1B-attenuated adenovirus in drug-resistant ovarian tumour cells is associated with reduced apoptosis.
Ganly I; Kim YT; Hann B; Balmain A; Brown R
Gene Ther; 2001 Mar; 8(5):369-75. PubMed ID: 11313813
[TBL] [Abstract][Full Text] [Related]
18. An E1B-19 kDa gene deletion mutant adenovirus demonstrates tumor necrosis factor-enhanced cancer selectivity and enhanced oncolytic potency.
Liu TC; Hallden G; Wang Y; Brooks G; Francis J; Lemoine N; Kirn D
Mol Ther; 2004 Jun; 9(6):786-803. PubMed ID: 15194046
[TBL] [Abstract][Full Text] [Related]
19. 'Autoreplication' of the vector genome in recombinant adenoviral vectors with different E1 region deletions and transgenes.
Marienfeld U; Haack A; Thalheimer P; Schneider-Rasp S; Brackmann HH; Poller W
Gene Ther; 1999 Jun; 6(6):1101-13. PubMed ID: 10455413
[TBL] [Abstract][Full Text] [Related]
20. Melanoma cultures show different susceptibility towards E1A-, E1B-19 kDa- and fiber-modified replication-competent adenoviruses.
Schmitz M; Graf C; Gut T; Sirena D; Peter I; Dummer R; Greber UF; Hemmi S
Gene Ther; 2006 Jun; 13(11):893-905. PubMed ID: 16482201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
